Degarelix
Degarelix is used for the treatment of advanced prostate cancer. Degarelix is a synthetic peptide derivative drug which binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocks interaction with GnRH.
| Catalog Number | API214766786 |
| Alternative Name(s) | Firmagon Uglypeptide1 SX0XJI3A11 |
| Research Area | Anti-Tumor APIs |
| Molecular Formula | C82H103ClN18O16 |
| CAS# | 214766-78-6 |
| SMILES | CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/degarelix-item-6102.html |